> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Blood Donor Screening in an Ebola Outbreak
- URL: https://www.fdaweb.com/blood-donor-screening-in-an-ebola-outbreak/
- Published: 2026-07-06T12:00:00.000Z
- Updated: 2026-09-14T13:42:19.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5161396

FDA has published a guidance, *Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral, and Blood Product Management in Response to an Ebola Disease Outbreak*, notifying blood collection establishments of the agency’s determination of Ebola to be a transfusion-transmitted infection. The [document](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/recommendations-assessment-blood-donor-eligibility-donor-deferral-and-blood-product-management?ref=fdaweb.com) includes the agency’s recommendations for assessing blood donor eligibility, donor deferral, and blood product management in the event of an Ebola disease outbreak in at least one country.

The guidance was developed in response to the 2014 Ebola outbreak in West Africa, FDA says, but it expects the recommendations to apply to all Orthoebolaviruses that cause Ebola in humans should an Ebola disease outbreak occur.

The guidance updates a 1/2017 guidance that finalized a 12/2015 draft. FDA says the updates involve minor changes.